Predicted Trait | |
Reported Trait | Hypertrophic cardiomyopathy (MTAG) |
Mapped Trait(s) | hypertrophic cardiomyopathy (EFO_0000538) |
Additional Trait Information | Multi-trait analysis incorporating LV end-systolic volume, global LV circumferential strain, LV concentricity |
Score Construction | |
PGS Name | hcm.mtag |
Development Method | |
Name | PRS-CS |
Parameters | Genome-wide |
Variants | |
Original Genome Build | hg19 |
Number of Variants | 374,114 |
Effect Weight Type | beta |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000642 |
Citation (link to publication) | Zheng SL et al. Nat Genet (2025) |
Ancestry Distribution | |
Source of Variant Associations (GWAS) | European: 100% 74,259 individuals (100%) |
PGS Evaluation | European: 100% 1 Sample Sets |
Study Identifiers
|
Sample Numbers
|
Sample Ancestry
|
Cohort(s)
|
---|---|---|---|
Europe PMC: 10.1101/2023.01.28.23285147v2 | [
| European | BRRD, GEL, HCMR, RBH-CRB |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source
|
Trait
|
PGS Effect Sizes (per SD change) |
Classification Metrics
|
Other Metrics
|
Covariates Included in the Model
|
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM021367 | PSS011704| European Ancestry| 343,182 individuals | PGP000642 | Zheng SL et al. Nat Genet (2025) | Reported Trait: Hypertrophic cardiomyopathy | HR: 2.34 OR: 1.33 | AUROC: 0.8 | R²: 0.048 Odds ratio (OR, high vs median tertile): 5.9 | age, age^2, sex, PC1-10 | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods
|
Participant Follow-up Time
|
Sample Numbers
|
Age of Study Participants
|
Sample Ancestry
|
Additional Ancestry Description
|
Cohort(s)
|
Additional Sample/Cohort Information
|
---|---|---|---|---|---|---|---|---|
PSS011704 | — | — | [
| — | European | — | UKB | — |